Publication:
RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6

Placeholder

Organizational Units

Program

KU Authors

Co-Authors

Szenker-Ravi, Emmanuelle
Altunoglu, Umut
Leushacke, Marc
Boss-Lefevre, Celia
Khatoo, Muznah
Tran, Hong Thi
Naert, Thomas
Noelanders, Rivka
Hajamohideen, Amin
Beneteau, Claire

Advisor

Publication Date

Language

English

Journal Title

Journal ISSN

Volume Title

Abstract

The four R-spondin secreted ligands (RSPO1-RSPO4) act via their cognate LGR4, LGR5 and LGR6 receptors to amplify WNT signalling 1-3 . Here we report an allelic series of recessive RSPO2 mutations in humans that cause tetra-amelia syndrome, which is characterized by lung aplasia and a total absence of the four limbs. Functional studies revealed impaired binding to the LGR4/5/6 receptors and the RNF43 and ZNRF3 transmembrane ligases, and reduced WNT potentiation, which correlated with allele severity. Unexpectedly, however, the triple and ubiquitous knockout of Lgr4, Lgr5 and Lgr6 in mice did not recapitulate the known Rspo2 or Rspo3 loss-of-function phenotypes. Moreover, endogenous depletion or addition of exogenous RSPO2 or RSPO3 in triple-knockout Lgr4/5/6 cells could still affect WNT responsiveness. Instead, we found that the concurrent deletion of rnf43 and znrf3 in Xenopus embryos was sufficient to trigger the outgrowth of supernumerary limbs. Our results establish that RSPO2, without the LGR4/5/6 receptors, serves as a direct antagonistic ligand to RNF43 and ZNRF3, which together constitute a master switch that governs limb specification. These findings have direct implications for regenerative medicine and WNT-associated cancers.

Description

Source:

Nature

Publisher:

Nature Publishing Group (NPG)

Keywords:

Subject

Science, Technology

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

0

Views

0

Downloads

View PlumX Details